6-Chloro-2-(difluoromethyl)-3-fluoropyridine, 95.0%, 10g

3-(6-FLUORO-1-OXO-2,3-DIHYDRO-1H-ISOINDOL-2-YL)PIPERIDINE-2,6-DIONE, 95%, 5g

2-Acetyl-5-bromothiophene, 97.00%, 5g

2,3-Dihydro-1H-inden-1-ylacetic acid, 95.0%, 10g

N1,N3-Bis(2,2,6,6-tetramethylpiperidin-4-yl)isophthalamide>96.0%(GC)(T)25g

1-Fluoro-2-isobutoxy-3-nitrobenzene, 95.0%, 1g

1-(2-Fluoro-benzyl)-1 H -pyrazol-4-ylamine, 95.0%, 1g

Pyridin-2-yl trifluoromethanesulfonate, 98+%, 5g

4-Bromothieno[3,2-c]pyridine, 95%, 100mg

1,3-BIS(((S)-2-OXO-3-(4-(3-OXOMORPHOLINO)PHENYL)OXAZOLIDIN-5-YL)METHYL)UREA, 95%, 100mg

Colonne capillaire GC ROTI®Cap-5 MS Ultra, 30 m, 0,32 mm, 0,50 µm, 1 pièce(s)

1-Phenyl-5-(trifluoromethyl)pyrazole-4-carboxylic acid, 95.0%, 5g

[1-(4-chlorophenyl)ethyl]methylamine hydrochloride, 95.0%, 5g